24897 Cabergoline From Par Pharm With Cabergoline 0.5mg listed at Acne Zits Drugs

The Ingredients: Cabergoline
Dosage Form and Administration: Tablet; Oral
Drug Trade Name: Cabergoline
Firm: Par Pharm
Strength: 0.5MG
New Drug Application Type: A
The Drug Application Number: 76310
Medicine Product Number: 1
Approval Date: 12/29/2005
Reference Listed Drug: Yes
Type: RX
Applicant Full Name: Par Pharmaceutical Inc
Local Number: 24897

Hormonal Acne Treatments

In females, hormonal treatments can improve acne. The common combined oestrogen and progestogen methods of hormonal contraception have some effect, but the antiandrogen, Cyproterone, in combination with an oestrogen (Diane-35) is particularly effective at reducing androgenic hormone levels. Diane-35 is not available in the USA, but a newer oral contraceptive containing the progestin drospirenone is now available with fewer side effects than Diane-35 or Dianette. Diane-35 is effective where blood tests show abnormally high levels of androgens. Along with this, treatment with low dose spironolactone can have anti-androgenetic properties, especially in patients with polycystic ovarian syndrome.

Continuity of Care

Continuity of care is essential for drug abusers re-entering the community. Drug users who complete treatment in prison and continue with treatment in the community have low relapse rates. Continuing drug abuse treatment helps released offender deal with problems that become relevant only after prison, such as learning to handle situations that could lead to relapse, learning how to live without drugs in the community and how to develop a peer support network. Treatment in prison or jail can begin a process of therapeutic change, resulting in reduced drug use and criminal behavior after incarceration. Continuing drug treatment in the community is essential to sustaining abstinence.

Balanced Approach

A balance of rewards and sanctions encourages positive social behavior and treatment participation. When providing correctional supervision of individuals participating in drug abuse treatment, it is important to reinforce positive behavior. Nonmonetary social rewards such as recognition for progress or sincere effort are effective, as are graduated sanctions that are consistent, predictable and clear responses to noncompliant behavior. Generally, treatment specialists implement less punitive responses for early and less serious noncompliance, with increasingly severe sanctions issued for continued problem behavior. Rewards and sanctions are most likely to have the desired effect when they are fair and when they swiftly follow the targeted behavior.